Central and peripheral RAG protein re-expression: Underestimate mechanisms of tolerance?

Scandinavian Journal of Immunology

Volumn 64, Issue 3, 2006, Pages 185-189

  Hillion, S ^a   Rochas, C ^a   Devauchelle, V ^a   Youinou, P ^a   Jamin, C ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; RAG1 PROTEIN; RAG2 PROTEIN;

APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; DNA RECOMBINATION; ECTOPIC THYROID GLAND; GENE; GENE REARRANGEMENT; GENETIC RECOMBINATION; GERMINAL CENTER; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SOMATIC HYPERMUTATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; BONE MARROW; DNA-BINDING PROTEINS; GERMINAL CENTER; HOMEODOMAIN PROTEINS; HUMANS; IMMUNE TOLERANCE; MICE; MODELS, IMMUNOLOGICAL;

EID: 33747056584     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01801.x     Document Type: Review

References (52)

1. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem 2002;71:101-32.
2. Nemazee D, Buerki K. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci U S A 1989;86:8039-43.
3. Goodnow CC, Crosbie J, Adelstein S et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676-82.
4. Gay D, Saunders T, Camper S, Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 1993;177:999-1008.
5. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003;301:1374-7.
6. Hao Z, Rajewsky K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med 2001;194:1151-64.
7. Radic MZ, Erikson J, Litwin S, Weigert M. B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med 1993;177:1165-73.
8. Retter MW, Nemazee D. Receptor editing occurs frequently during normal B cell development. J Exp Med 1998;188:1231-8.
9. Brauninger A, Goossens T, Rajewsky K, Kuppers R. Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human. Eur J Immunol 2001;31:3631-7.
10. Wilson PC, Wilson K, Liu YJ, Banchereau J, Pascual V, Capra JD. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. J Exp Med 2000;191:1881-94.
11. Radic MZ, Zouali M. Receptor editing, immune diversification, and self-tolerance. Immunity 1996;5:505-11.
12. Zhang Z, Zemlin M, Wang YH et al. Contribution of Vh gene replacement to the primary B cell repertoire. Immunity 2003;19:21-31.
13. Grimaldi CM, Hicks R, Diamond B. B cell selection and susceptibility to autoimmunity. J Immunol 2005;174:1775-81.
14. Jankovic M, Casellas R, Yannoutsos N, Wardemann H, Nussenzweig MC. RAGs and regulation of autoantibodies. Annu Rev Immunol 2004;22:485-501.
15. Pelanda R, Torres RM. Receptor editing for better or for worse. Curr Opin Immunol 2006;18:184-90.
16. Tze LE, Schram BR, Lam KP et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol 2005;3:e82.
17. Meade J, Fernandez C, Turner M. The tyrosine kinase Lyn is required for B cell development beyond the T1 stage in the spleen: rescue by over-expression of Bcl-2. Eur J Immunol 2002;32:1029-34.
18. Diamant E, Keren Z, Melamed D. CD19 regulates positive selection and maturation in B lymphopoiesis: lack of CD19 imposes developmental arrest of immature B cells and consequential stimulation of receptor editing. Blood 2005;105:3247-54.
19. Hayashi K, Nojima T, Goitsuka R, Kitamura D. Impaired receptor editing in the primary B cell repertoire of BASH-deficient mice. J Immunol 2004;173:5980-8.
20. Middendorp S, Hendriks RW. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing. J Immunol 2004;172:1371-9.
21. Inlay MA, Tian H, Lin T, Xu Y. Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement. J Exp Med 2004;200:1205-11.
22. Quong MW, Martensson A, Langerak AW, Rivera RR, Nemazee D, Murre C. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J Exp Med 2004;199:1101-12.
23. Verkoczy L, Ait-Azzouzene D, Skog P et al. A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity 2005;22:519-31.
24. Hikida M, Mori M, Takai T, Tomochika K, Hamatani K, Ohmori H. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science 1996;274:2092-4.
25. Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 1996;274:2094-7.
26. Gartner F, Alt FW, Monroe RJ, Seidl KJ. Antigen-independent appearance of recombination activating gene (RAG)-positive bone marrow B cells in the spleens of immunized mice. J Exp Med 2000;192:1745-54.
27. Girschick HJ, Grammer AC, Nanki T, Mayo M, Lipsky PE. RAG1 and RAG2 expression by B cell subsets from human tonsil and peripheral blood. J Immunol 2001;166:377-86.
28. Meffre E, Papavasiliou F, Cohen P et al. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells. J Exp Med 1998;188:765-72.
29. Magari M, Sawatari T, Kawano Y et al. Contribution of light chain rearrangement in peripheral B cells to the generation of high-affinity antibodies. Eur J Immunol 2002;32:957-66.
30. William J, Euler C, Christensen S, Shlomchik MJ. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002;297:2066-70.
31. Meru N, Jung A, Baumann I, Niedobitek G. Expression of the recombination-activating genes in extrafollicular lymphocytes but no apparent reinduction in germinal center reactions in human tonsils. Blood 2002;99:531-7.
32. Dono M, Burgio VL, Tacchetti C et al. Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur J Immunol 1996;26:2035-42.
33. Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 1987;236:77-81.
34. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T. Rheumatoid factor secretion from human Leu-1+ B cells. Science 1987;236:81-3.
35. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996;274:1906-9.
36. Hillion S, Saraux A, Youinou P, Jamin C. Expression of RAG in peripheral B cells outside germinal centers is associated with the expression of CD5. J Immunol 2005;174:5553-61.
37. + B cells in nonorgan-specific autoimmune diseases: a fresh look. Lupus 2001;10:523-5.
38. Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today 1999;20:312-6.
39. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells. J Exp Med 2000;191:883-9.
40. Li Y, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002;195:181-8.
41. Klonowski KD, Monestier M. Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors. J Immunol 2000;165:4487-93.
42. Yurasov S, Wardemann H, Hammersen J et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005;201:703-11.
43. Pugh-Bernard AE, Silverman GJ, Cappione AJ et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001;108:1061-70.
44. Cappione A, Anolik JH, Pugh-Bernard A et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 2005;115:3205-16.
45. - B cells of patients with childhood systemic lupus erythematosus. Ann Rheum Dis 2006;65:482-7.
46. Girschick HJ, Grammer AC, Nanki T, Vazquez E, Lipsky PE. Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus. Arthritis Rheum 2002;46:1255-63.
47. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E. Human B cell tolerance and its failure in rheumatoid arthritis. Ann NY Acad Sci 2005;1062:116-26.
48. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 2005;201:1659-67.
49. Zhang Z, Wu X, Limbaugh BH, Bridges SL Jr. Expression of recombination-activating genes and terminal deoxynucleotidyl transferase and secondary rearrangement of immunoglobulin kappa light chains in rheumatoid arthritis synovial tissue. Arthritis Rheum 2001;44:2275-84.
50. Itoh K, Meffre E, Albesiano E et al. Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J Exp Med 2000;192:1151-64.
51. Faber C, Morbach H, Singh SK, Girschick HJ. Differential expression patterns of recombination activating genes in individual mature B cells in juvenile idiopathic arthritis. Ann Rheum Dis. Published online 27 Feb 2006 doi: 10.1136/ard.2005.047878.
52. Armengol MP, Juan M, Lucas-Martin A et al. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am J Pathol 2001;159:861-73.